Cell-free DNA: measurement in various carcinomas and establishment of normal reference range.

BACKGROUND Cell-free DNA is detectable in circulating blood. Numerous reports in the literature have pointed out that cell-free DNA in plasma or serum has the clinical potential to be a more specific tumor marker for the diagnosis and prognosis, as well as the early detection, of cancer. METHODS In order to adapt cell-free DNA to a routine clinical laboratory test, we used commercial kits such as the QIAamp blood kit for DNA extraction and the PicoGreen DNA kit for DNA quantification. This was done so our results and the normal reference value established would allow to be compared by other laboratories. We have established the normal reference level of cell-free DNA for females and males from age 20-70 years. We also detected elevated cell-free DNA in all cancers that were tested in this study, including carcinomas, leukemia and lymphoma. RESULTS Our study indicates that the elevation of serum cell-free DNA was usually detected in specimens containing elevated tumor markers and is most likely associated with tumor metastases. The electrophoretic pattern of cell-free DNA showed that cell-free DNA from cancer patient is fragmented, containing smaller DNA (100 bp) not found in normal cell-free DNA. CONCLUSIONS Measuring cell-free DNA may complement currently used tumor markers for the management of cancer patients.

[1]  L. Mariani,et al.  Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients. , 2001, Cancer research.

[2]  M. Muers,et al.  Genetic alterations in bronchial mucosa and plasma DNA from individuals at high risk of lung cancer , 2001, International journal of cancer.

[3]  J. Jen,et al.  An Overview on the Isolation and Analysis of Circulating Tumor DNA in Plasma and Serum , 2000, Annals of the New York Academy of Sciences.

[4]  K. Iczkowski,et al.  Cell-free DNA in human blood plasma: length measurements in patients with pancreatic cancer and healthy controls. , 1998, Pancreas.

[5]  M. Stroun,et al.  Isolation and characterization of DNA from the plasma of cancer patients. , 1987, European journal of cancer & clinical oncology.

[6]  D. Morton,et al.  Clinical Significance of Circulating DNA Microsatellite Markers in Plasma of Melanoma Patients , 2000, Annals of the New York Academy of Sciences.

[7]  F Mayall,et al.  Microsatellite abnormalities in plasma of patients with breast carcinoma: concordance with the primary tumour. , 1999, Journal of clinical pathology.

[8]  M. E. Paschoal,et al.  In vitro interaction of serum protein with circulating DNA of lung cancer patient. , 1999, International journal of molecular medicine.

[9]  I. Petersen,et al.  Detection of Microsatellite Alterations in the DNA Isolated from Tumor Cells and from Plasma DNA of Patients with Lung Cancer , 2000, Annals of the New York Academy of Sciences.

[10]  A. Simpson,et al.  Circulating tumor‐derived DNA may permit the early diagnosis of head and neck squamous cell carcinomas , 2001, International journal of cancer.

[11]  Boland Cr.  Setting microsatellites free. , 1996 .

[12]  David Sidransky,et al.  Microsatellite alterations in serum DNA of head and neck cancer patients , 1996, Nature Medicine.

[13]  G. Capellá,et al.  K-ras mutations in DNA extracted from the plasma of patients with pancreatic carcinoma: diagnostic utility and prognostic significance. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  H. Mulcahy,et al.  Detection of Circulating Tumour DNA in the Blood (Plasma/Serum) of Cancer Patients , 2004, Cancer and Metastasis Reviews.

[15]  F. O. Fackelmayer,et al.  DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. , 2001, Cancer research.

[16]  B. Shapiro,et al.  Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease , 1983, Cancer.

[17]  F. Laval,et al.  Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours. , 1995, Cancer letters.

[18]  D. Swinkels,et al.  Detection of tumour DNA in serum of colorectal cancer patients. , 1997, Scandinavian journal of clinical and laboratory investigation.

[19]  H. Bonnefoi,et al.  Detecting tumor-related alterations in plasma or serum DNA of patients diagnosed with breast cancer. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.